BIOMAT Database Logo BIOMAT Database Logo

[Diagnostic importance of lysozymemia and lysozymuria in hematology]. 1978

L I Iavorkovskiĭ, and Kh Ia Grant

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

L I Iavorkovskiĭ, and Kh Ia Grant
Clinical diagnostic value of lysozymuria.
January 1971, Advances in nephrology from the Necker Hospital,
L I Iavorkovskiĭ, and Kh Ia Grant
[Diagnostic significance of lysozymuria in chronic pyelonephritis].
January 1980, Vutreshni bolesti,
L I Iavorkovskiĭ, and Kh Ia Grant
[Diagnostic significance of muramidasuria (lysozymuria) after kidney transplantation].
November 1976, Klinicheskaia meditsina,
L I Iavorkovskiĭ, and Kh Ia Grant
Diagnostic value of the early assay of lysozymuria and proteinuria in endemic nephropathy.
January 1973, Revue roumaine de medecine interne (1964),
L I Iavorkovskiĭ, and Kh Ia Grant
Lysozymuria in diabetes.
March 1976, British medical journal,
L I Iavorkovskiĭ, and Kh Ia Grant
[Lysozymuria in leukemias].
January 1973, Folia haematologica (Leipzig, Germany : 1928),
L I Iavorkovskiĭ, and Kh Ia Grant
[DIAGNOSTIC ISOTOPES IN HEMATOLOGY].
November 1964, Helvetica medica acta,
L I Iavorkovskiĭ, and Kh Ia Grant
The importance of microbiota in hematology.
April 2022, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
L I Iavorkovskiĭ, and Kh Ia Grant
[Clinical importance of karyotype in hematology].
January 1994, Schweizerische medizinische Wochenschrift,
L I Iavorkovskiĭ, and Kh Ia Grant
Lysozymuria and gentamicin nephrotoxicity.
July 1980, The New England journal of medicine,
Copied contents to your clipboard!